Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Abstract Current classes of cancer therapeutics have negative side effects stemming from off-target cytotoxicity. One way to avoid this would be to use a drug delivery system decorated with targeting moieties, such as an aptamer, if a targeted aptamer is available. In this study, aptamers were selec...
Saved in:
Main Authors: | Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan, Mark Wunderlich, Bahareh Hosseinpour, Bianca S. Bono, Melissa J. Chee, James C. Mulloy, William G. Willmore, Maria C. DeRosa, Edward J. Merino |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/17d8b5d0007c474daed087ef61f4e1db |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.
by: Yuanyuan Wang, et al.
Published: (2014) -
Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX
by: Guodong Wang, et al.
Published: (2017) -
MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
by: Xinyue Chen, et al.
Published: (2019) -
Selection of aptamers for mature white adipocytes by cell SELEX using flow cytometry.
by: Eun Young Kim, et al.
Published: (2014) -
Publisher Correction: MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
by: Xinyue Chen, et al.
Published: (2020)